Increased 68Ga-FAPI Uptake in Active Atherosclerotic Plaque

Clin Nucl Med. 2022 Jun 1;47(6):545-546. doi: 10.1097/RLU.0000000000004103. Epub 2022 Feb 16.

Abstract

A 67-year-old man with esophageal cancer was included in a clinical trial of a 68Ga-FAPI PET/CT study on tumors (ChiCTR2100044131). Increased tracer uptake was noted in the esophageal cancer with esophagitis. In addition, active coronary atherosclerotic plaque also revealed increased FAPI activity.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Esophageal Neoplasms*
  • Humans
  • Male
  • Plaque, Atherosclerotic* / diagnostic imaging
  • Positron Emission Tomography Computed Tomography
  • Quinolines*
  • Rare Diseases

Substances

  • 68Ga-FAPI
  • Quinolines